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Background: Parkinson’s disease is a high incidence neurodegenerative disease in elderly people, and oxidative
stress plays an important role in the pathogenesis. Oxygen metabolism in the brain is high, which lacks an
antioxidative protection mechanism. Recently, it has been found that polyphenols play an important role in
antioxidation. (−)-epigallocatechin-3-gallate (EGCG) is an important component of tea polyphenols and its biological
effects, such as strong antioxidation, scavenging of free radicals and anti-apoptosis, can pass through the blood
brain barrier. The SIRT1/PGC-1α signaling pathway has not been reported in PC12 cells. Therefore, research of the
protective mechanism of EGCG in PC12 cells damaged by -methyl-4-phenyl-pyridine (MMP+) may provide a new
insight into protect against and treatment of Parkinson’s disease.
Methods: MPP+-treated highly differentiated PC12 cells were used as the in vitro cell model. An MTT assay was
used to investigate cell viability after EGCG treatment, a dichlorofluorescin diacetate assay was used to measure
reactive oxygen species (ROS) production, western blot analysis was used to observe PGC-1α and SIRT1 protein
expression, and real-time PCR to observe PGC-1α, SOD1 and GPX1 mRNA expression.
Results: PC12 cell viability was significantly reduced after MPP+ treatment by 11.46% compared with that of the
control (P< 0.05). However, cell viability was unchanged by 10 μmol/L EGCG treatment. In co-treatments with
EGCG and MPP+, cell viability was significantly increased by 12.92% (P< 0.05) and MPP+-induced ROS production
was markedly decreased. PGC-1α mRNA expression was obviously upregulated by 21.51% (P< 0.05), and SOD1 and
GPX1 mRNA expression was slightly increased by 12.94% and 15.63% (P> 0.05), respectively, by treatment with
EGCG and then MPP+ for 12 h. The mRNA expression of PGC-1α, SOD1 and GPX1 was increased by 25.17%, 40%
and 146% (all P< 0.05), respectively, by treatment with EGCG and then MPP+ for 24 h. Such effects were not
observed with MPP+ treatment alone.
Conclusion: The SIRT1/PGC-1α pathway is one of the mechanisms of EGCG suppression of MPP+-induced injury of
PC12 cells.
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Polyphenols are present in green tea extract, and many
studies have shown that polyphenols have strong anti-
oxidant and -apoptosis activities [1]. Most of the benefits of
green tea are due to the most prominent biological activity
of the green tea catechin (−)-epigallocatechin-3-gallate
(EGCG) [2]. Oxidative stress and cell apoptosis play an im-
portant role in the pathogenesis of Parkinson’s disease [3].
Therefore, we considered whether EGCG has a protective
effect against Parkinson’s disease. The role of the silent mat-
ing type information regulation 2 homolog (SIRT1)/peroxi-
somal proliferator-activated receptor- coactivator 1 (PGC-
1α) signaling pathway in oxidative stress induced by
1-methyl-4-phenyl-pyridine (MPP+) in PC12 cells and
whether EGCG is antagonized in PC12 cells with
MPP+-induced oxidative stress via the SIRT1/PGC-1α
cell signaling pathway have not been reported. In this
study, PC12 cells were used as a model of dopamin-
ergic neurons with MPP+-induced cell injury, and the
protective effect and mechanism of EGCG suppres-
sion of MPP+-induced cell injury were analyzed to
provide a biological basis for prevention and treat-
ment of Parkinson's disease.
Methods
Reagents
Cell culture reagents were purchased from Hyclone
(Logan, UT, USA). Acrylamide and western blot reagents
were purchased from Bio-Rad (Hercules,California, USA).
MPP+ and EGCG were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Anti-PGC-1α and -SIRT1 anti-
bodies were purchased from Santa Cruz Biotechnology
Inc. (Santa Cruz, CA, USA). Anti-actin antibody, goat
anti-rabbit and goat anti-mouse IgG were purchased from
Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.
Superoxide dismutase 1 (SOD1) and glutathione peroxid-
ase 1 (GPX1) primers were synthesized by Shanghai Bio-
logical Engineering Company. 3-(4,5 dimethylthiazole-2yl
)-2,5-diphenyl tetrazolium bromide thiazolyl blue (MTT)
was purchased from Wuhan Ling fly Technology Co., Ltd.
Dichlorofluorescin diacetate (DCFH-DA) was purchased
from the Beyotime Institute of Biotechnology (Shanghai,
China). All other reagents were purchased from Chinese
suppliers.
Cell culture
Highly differentiated PC12 cells, obtained from the Chin-
ese Academy of Sciences Committee Type Culture Collec-
tion cell bank, were cultured in 100 mm plates in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (v/v) fetal bovine serum (FBS),
100 U/ml penicillin and 100 U/ml streptomycin. Cells
were incubated at 37 °C in a humidified incubator (Model
No. 3130; Forma Scientific) supplemented with 5% CO2and cultured to 80–90% confluency before being passa-
ging or use in experimentation.
MTT assay to evaluate cell survival
Cells were plated at 1 × 104 cells/well in 96 well plates,
cultured, differentiated and treated as described above.
Then, PC12 cells were treated with various concentra-
tions of EGCG (2.5, 5, 10, 20 and 40 μmol/L) and/or
MPP+ (125, 250, 500, 1000 and 2000 μmol/L) for 24 h.
Then, treatment solutions were discarded, and cells were
washed gently with PBS. MTT (20 μl) at 0.5 mg/ml and
medium (200 μl) were then added to each well. After in-
cubating for 4 h at 37 °C, with 5% CO2, the solution was
removed, and 150 μl dimethyl sulfoxide was added to
each well. The optical density (OD) was evaluated at
570 nm by a microplate reader after the precipitate in
each well was dissolved for 10 min.
Preparation of cell lysates
PC12 cells were washed several times with ice-cold
phosphate buffered saline (PBS), resuspended in RIPA
lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Tri-
ton X-100, 1% sodium deoxycholate, 0.1% sodium dode-
cyl sulfate (SDS), 2 mM sodium orthovanadate, 25 mM
sodium fluoride, 1 mM EDTA and 0.5 mM phenyl-
methanesulfonyl fluoride and incubated for 10 min on
ice. Lysates were then centrifuged at 12,000 × g for
10 min at 4 °C.
Detection of intracellular reactive oxygen species (ROS)
To measure ROS in differentiated PC12 cells produced
by MPP+ treatment, we used a DCFH-DA assay. DCFH-
DA is a fluorescent dye that crosses the cell membrane
and is enzymatically hydrolyzed by intracellular esterases
to non-fluorescent DCFH. Cells were plated at 4 × 105
cells per 6 well dish. Differentiated PC12 cells were pre-
treated with 10 μmol/L EGCG for 1 h and then treated
with 500 μM MPP+ for 24 h. Cells were then incubated
with DCFH-DA at a final concentration of 10 μM in
high-glucose DMEM without FBS for 20 min at 37 °C,
washed three times with DMEM and analyzed using a
FACSCalibur flow cytometer (Becton Dickinson, San Jose,
CA, USA). For each analysis, 10,000 events were recorded.
Western blot analysis
Thirty micrograms of protein were loaded per lane and
resolved by 10% SDS-polyacrylamide gel electrophoresis
for 90 min at 80 V. Separated proteins were transferred
to polyvinylidene fluoride membranes (Millipore) for 2 h
at 140 V with a Bradford reagent (Bio-Rad, CA). Mem-
branes were blocked with 5% skim milk in PBS contain-
ing 0.05% Tween 20 for 1 h at room temperature. Then,
membranes were incubated with primary antibodies
against PGC-1α (Lot#: B2510, Santa Cruz), SIRT1 (Lot#:
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with a horseradish peroxidase-coupled secondary anti-
body. Specific bands were visualized using an enhanced
chemiluminescence detection kit (Cat#:: AR1170; Millipore,
Billerica, Massachusetts,America).
RNA isolation and real-time RT-PCR
Total RNA was isolated from PC12 cells using TRIzol
reagent (Invitrogen, CA) according to the manufacturer’s
protocol. Total RNA purity and integrity was confirmed
by an ND-1000 NanoDrop (NanoDrop Technologies)
and 2100 Bioanalyzer (Agilent). Real-time PCR was per-
formed using an ABI prism 7500 HT sequence detection
system (Applied Biosystems, Foster City, CA) based on
the 59-nuclease assay [4] for the genes indicated and the
housekeeping gene glyceraldehyde-3-phosphate dehydro-
genase. Relative expression was calculated using the ΔΔCt
method [5]. PCR amplification was carried out with cDNA
equivalent to 10 ng starting mRNA using specific oligo-
nucleotide primers for PGC-1α (forward, 5’-CAATGAAT
GCAGCGGTCTTA-3’, reverse, 5’-ACGTCTTTGTGGCT
TTTGCT-3’), SOD1 (forward, 5’-CGGCTTCTGTCGTC
TCCTTGCTT-3’, reverse, 5’-AACTGGTTCACCGCTTG





































Figure 1 EGCG and MPP+ affect PC12 cell viability. (A) MPP+-induced P
2000 μmol/L (*P< 0.05;**P< 0.01 vs. vehicle control). (B) PC12 cell viability
40 μmol/L (**P< 0.01 vs. vehicle control). (C) Treatment with EGCG and th




Data were analyzed and expressed as the mean± stand-
ard error of the mean. Comparisons were made using
analysis of variance and the Newman-Keuls multiple
comparisons test. A value of P< 0.05 was considered
statistically significant.
Results
EGCG suppresses decreased PC12 cell viability induced by
MPP+
To evaluate the cell viability of differentiated PC12 cells
after exposure to oxidative injury, PC12 cells were treated
with various concentrations of MPP+ (125–2000 μmol/L)
for 24 h. Different concentrations of MPP+ significantly
decreased cell viability in a dose-dependent manner
(Figure 1A). As an optimal MPP+ concentration,
500 μmol/L MPP+ was selected for subsequent experi-
ments, because cell viability was deceased by 38.2%
(P = 0.011) (Figure 1A). We investigated the neuropro-
tective effects of EGCG, which showed no cytotoxic ef-



















C12 cell viability. MPP+ concentrations were 0, 125, 250, 500, 1000 and
after EGCG treatment. EGCG concentrations were 0, 2.5, 5, 10, 20 and
en MPP+ affects PC12 cell viability. Groups were: control, 500 μmol/L
ehicle control, **P< 0.01 vs. MPP+ treatment alone).
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was significantly attenuated (Figure 1B). PC12 cells
were pretreated with 10 μmol/L EGCG for 1 h and then
treated with 500 μmol/L MPP+ for 24 h. An MTT assay
indicated that the cell viability of PC12 cells treated
with EGCG and then MPP + was significantly increased
by 12.92% (P< 0.05) compared with that of MPP+ treat-
ment alone. However, there was no significant differ-
ence compared with the cell viability of the control
(P> 0.05) (Figure 1C).EGCG attenuates intracellular ROS production by MPP
+-induced oxidative stress
To measure intracellular ROS production in PC12 cells
after MPP+ treatment and the effect of EGCG on ROS
production, we used a DCFH-DA assay. As shown inFigure 2 EGCG attenuates intracellular ROS production after MPP+-in
various groups. Data. 01: negative control, control group without DCFH-DA
Data.03: control group with DCFH-DA; Data.04: 500 μM MPP+; Data.05: 10 μ
production was determined by DCFH-DA fluorescence.Figure 2, MPP+ increased ROS production by 19.77%,
compared with that in the control. Pretreatment with
EGCG (10 μM) resulted in intracellular ROS production
decreasing by 13.95%, compared with that of MPP+ treat-
ment alone. EGCG alone also attenuated ROS production
by 2.6%, compared with that in the control. These results
indicated that EGCG treatment significantly suppressed
intracellular ROS production in PC12 cells, compared
with that in the control and MPP+ treatment alone.
Therefore, EGCG showed a significant protective effect
against MPP+-induced oxidative stress (Figure 2).PGC-1α and SIRT1 protein expression is enhanced by
EGCG pretreatment of MPP+-treated PC12 cells
Western blot showed that there were protein bands at
120, 90 and 42 kDa (Figure 3). PGC-1α and SIRT1duced oxidative stress. PC12 cells were treated as indicated by the
; Data.02: positive control, control group with DCFH-DA and rosup;
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Figure 3 Effect of MPP+ and EGCG on PGC-1α and SIRT1
protein expression in PC12 cells. (A) vehicle-only control, (B) MPP
+ alone, MPP+ 500 μmol/L, (C) EGCG alone, 10 μmol/L EGCG, (D)
10 μmol/L EGCG+ 500 μmol/L MPP+ (treatment with EGCG for
30 min, followed by MPP+ treatment). Results show that EGCG
pretreatment could enhance PGC-1α and SIRT1 protein expression,
and this up-regulation was higher than respective treatments with
MPP+ and EGCG alone. β-actin was used as an internal reference.
*P< 0.05 vs. vehicle-only control.
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treated with EGCG and then MPP+, compared with
those in the control. PGC-1α protein expression was sig-
nificantly elevated by 25.91% (P< 0.05), and SIRT1Figure 4 Effect of MPP+ and EGCG on PGC-1α, GPX1 and SOD1 mRNA
10 μmol/L EGCG, 10 μmol/L EGCG +500 μmol/L MPP+ for 12 h (treatment
EGCG+ 500 μmol/L MPP+ for 24 h (treatment with EGCG for 30 min, follow
obviously upregulated by 21.51% (P< 0.05), and SOD1 and GPX1 mRNA ex
+ for 12 h. PGC-1αz SOD1 and GPX1 mRNA expression were increased by 2
EGCG and then MPP+ for 24 h,.*P< 0.05 vs. vehicle-only control.protein expression was increased by 20.55% (P< 0.05)
after treatment with EGCG and then MPP+, compared
with that of MPP+ and EGCG treatments alone (Figure 3).
PGC-1α, SOD1 and GPX1 mRNA levels are elevated in a
time-dependent manner by EGCG pretreatment of MPP
+-treated PC12 cells for 12 and 24 h
Real-time PCR showed that PGC-1α, SOD1 and GPX1
mRNA expression was not significantly affected by MPP
+ and EGCG treatments alone, compared with those in
the control. PGC-1α mRNA expression was obviously
upregulated by 21.51% (P< 0.05), SOD1 and GPX1
mRNA expression was slightly increased by 12.94% and
15.63% (P> 0.05), respectively, by treatment with EGCG
and then MPP+ for 12 h. PGC-1α, SOD1 and GPX1
mRNA expression was increased by 25.17%, 40% and
146% (all P< 0.05), respectively, by treatment with
EGCG and then MPP+ for 24 h, compared with those by
MPP+ and EGCG treatments alone (Figure 4).
Discussion
Drinking at least two cups of green tea a day can reduce
the risk of Parkinson's disease [6]. Green tea extract con-
tains polyphenols that have strong biological effects such
as anti-oxidization, free radical scavenging, anti-apoptosis
and inhibition of monoamine oxidase B. In addition, poly-
phenols can pass through the blood brain barrier and may
be a drug candidate for treating neurodegenerative dis-
eases [7]. Most of the benefits of green tea are due to the
catechin EGCG, which is the most abundant and active
catechin in green tea [8,9].
In drug-induced nerve degeneration research, MPP +
has been widely used to study dopamine neurotoxicity,expression in PC12 cells. Groups were: control, 500 μmol/L MPP+,
with EGCG for 30 min, followed by MPP+ for 12 h), 10 μmol/L
ed by MPP+ for 24 h). Results show that PGC-1α mRNA expression was
pression was slightly increased by treatment with EGCG and then MPP
5.17%, 40% and 146% (all P< 0.05), respectively, by treatment with
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induce Parkinson’s disease-like symptoms in animals
[10]. MPP + is a mitochondrial complex I inhibitor and
can cause an absence of ATP and loss of membrane po-
tential in mitochondria, which leads to mitochondrial
dysfunction, increased production of oxygen free radicals
and cell damage [11]. PC12 cells derived from rat ad-
renal medulla pheochromocytoma, which are characterized
by catecholamine synthesis, metabolism and transport sys-
tem, are a cell model of Parkinson’s disease and have been
widely used in neuroscience research [12].
A previous study found that EGCG pretreatment can
significantly improve the survival of MPP+-treated PC12
cells in a dose-dependent manner. The protective effect
of EGCG reached a plateau at 5 and 10 μmol/L, which is
similar to the results of Mandel et al [13]. The dose-
dependency of the protective effect of EGCG may be
related to the cell type and high concentrations of MPP
+-induced oxidative stress. Free radicals can generate un-
saturated fatty acids, lipid peroxidation and oxidative
damage of proteins and DNA, which leads to cell degen-
eration and death. ROS have multiple effects on cell
function depending on the amount and subcellular loca-
tion of ROS. Some studies have reported that ROS are
involved in the apoptotic mechanism of MPP+-mediated
neurotoxicity. As mentioned previously, our data also
show that treatment with MPP+ results in a significant
increase of ROS, and ROS activity assays indicate that
pretreatment with EGCG significantly suppresses ROS
generation in PC12 cells, compared with that in the con-
trol and MPP+-treated cells (Figure 2). We also found
that EGCG shows a significant protective effect against
MPP+-induced toxicity.
The expression of SOD1 and GPX1, a typical class of
antioxidant enzymes, increases during oxidative stress,
which can remove ROS and reduce damage by oxidative
stress. PGC-1α, which is found in the anti-oxidative
stress system, plays a key role in transcriptional regula-
tion. PGC-1α is a multifunctional protein that can acti-
vate most nuclear receptors and also has a co-activation
function for many transcription factors [14]. When neu-
rons undergo oxidative stress, increased PGC-1α can
regulate the cell response in which oxidant hydrogen
peroxide increases the expression of PGC-1α, while the
expression of antioxidant enzyme genes, such as SOD1,
SOD2 and GPX1, significantly increase [15]. PGC-1α is
activated by oxidative stress and induces the expression
of antioxidant enzymes, which scavenge ROS and in-
crease the antioxidant capacity. SIRT1 has been recently
discovered as a class of nicotinamide adenine dinucleotide-
dependent histone deacetylase and its activation can main-
tain deacetylation of PGC-1α to activate the combination
of PGC-1α with chromatin to improve transcriptional activ-
ity. If PGC-lα is not bound to a transcription factor, thetranscriptional activity is very low. However, transcriptional
activity can be markedly elevated after SIRT1 and PGC-lα
are bound to each other [16]. Attenuated intracellular
SOD1 and GPX1 mRNA levels show that the protective ef-
fect of EGCG is related to scavenging intracellular oxygen
free radicals. PGC-1α and SIRT1 protein levels are
increased in PC12 cells, indicating that the antioxidant
properties of EGCG are related to the expression levels of
PGC-1α and SIRT1. PGC-1α, SOD1 and GPX1 mRNA
levels are elevated in a time-dependent manner, indicating
that the elevated SOD1 and GPX1 levels associated with
PGC-1α may be a result of EGCG regulation of PGC-1α
expression, which protects PC12 cells against MPP
+-induced injury.
Conclusions
EGCG, acting via the SIRT1/PGC-1α pathway, could in-
crease the expression of antioxidant enzymes, remove
free radicals and inhibit cell degeneration and death
caused by MPP+. EGCG may activate other pathways to
preserve PC12 cells against MPP+ damage, which
requires further study. The antioxidant EGCG can play
an effective protection role in the pathogenesis of Par-
kinson’s disease and is expected to become a therapeutic
drug for treating Parkinson’s disease.
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